Sarcoidosis
M. Dankyau
June 2023
Outline
Case studies
Introduction
Pathophysiology
Clinical features
Investigations
Treatment and Prognosis
Summary/Review questions
Conclusion
Case studies
Case 1 – Slide 1
Case 1 – Slide 2
Introduction
Sarcoidosis
Introduction 1
Introduction 2
Pathophysiology
Pathophysiology 1
Pathophysiology 2
Precise trigger is unknown, but there are some known risk factors
Genetic risk factors
Environmental risk factors
Spirochetes & Mycobacteria
Pathophysiology 3
Some drugs and exposures also associated with development of sarcoidosis and sarcoid-like granulomatosis.
Patients undergoing antiviral therapy for chronic hepatitis C
*monotherapy with IFN-alpha
*combination therapy with IFN-alpha and ribavirin
Pathological changes
Granulomas in sarcoidosis are noncaseating - there is no tissue necrosis at the centre of the granuloma, unlike other granulomatous diseases like tuberculosis.
Macrophages fuse together to form a single large multinucleated cell called a Langhans giant cell.
Pathological changes 2
Clinical features
Systemic Symptoms
Fever
Fatigue
Weight loss
Lungs (affecting over 90%)
Liver (affecting 20%)
Eyes (affecting 20%)
Skin (affecting 15%)
Lupus pernio
Heart (affecting 5%)
Kidneys (affecting 5%)
Central nervous system (5%)
Peripheral Nervous System (5%)
Musculoskeletal system(2%)
Lofgren’s Syndrome
Heerfordt-Waldenström syndrome
Staging based on Chest radiograph
Differential diagnosis: Granulomatous lung disease
Differential diagnosis: Granulomatous lung disease
Differential diagnosis: Granulomatous lung disease
Differential diagnosis: Granulomatous lung disease
Investigations
Histology
Gold standard for confirming the diagnosis of sarcoidosis is by histology from a biopsy.
Usually by doing bronchoscopy with ultrasound guided biopsy of mediastinal lymph nodes.
Histology shows characteristic non-caseating granulomas with epithelioid cells.
Caseating vs Noncaseating granuloma
Langhans giant cell
Blood Tests
Imaging
Chest xray shows hilar lymphadenopathy
High-resolution CT thorax shows hilar lymphadenopathy and pulmonary nodules
MRI scan show CNS involvement
PET scan can show active inflammation in affected areas
Chest radiograph in sarcoidosis
High Resolution CT - Hilar lymphadenopathy
Tests for other organ involvement
Treatment and prognosis
Treatment
Prognosis
Spontaneously resolves within 6 months in around 60% of patients.
In a small number of patients, it progresses with pulmonary fibrosis and pulmonary hypertension, potentially requiring a lung transplant.
Death usually occurs when it affects the heart (causing arrhythmias) or the central nervous system.
Summary
Flash cards
Questions
Flashcard 1
Flashcard 2
Flashcard 3
Flashcard 4
Summary
Conclusion
Bibliography